ionophores - CISMeF

Preferred Label : ionophores;

MeSH definition : Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes.;

MeSH synonym : Ionophore;

Wikipedia link : https://en.wikipedia.org/wiki/Ionophore;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D007476;

UMLS CUI

C0022022;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Ionophore (substance) [SNOMED CT concept]
- ionophore [IUPAC Term]
Indexing information
- 1,11-bis(8-quinolinyloxy)-3,6,9-trioxaundecane [MeSH Supplementary Concept]
- 16,16-dimethyl-15-dehydroprostaglandin B1 trimer [MeSH Supplementary Concept]
- 2,13-divaleryldibenzo-18-crown-6 [MeSH Supplementary Concept]
- 3'-hydroxydianemycin [MeSH Supplementary Concept]
- 3-decyl-1,5,8-triazacyclodecane-2,4-dione [MeSH Supplementary Concept]
- 4'-O-demethyldianemycin [MeSH Supplementary Concept]
- 4-bromo-A-23187 [MeSH Supplementary Concept]
- 6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedione [MeSH Supplementary Concept]
- A 204 [MeSH Supplementary Concept]
- A-130A [MeSH Supplementary Concept]
- A28086B [MeSH Supplementary Concept]
- CDA antibiotic [MeSH Supplementary Concept]
- CP 72588 [MeSH Supplementary Concept]
- CP 78545 [MeSH Supplementary Concept]
- DECYL-2 [MeSH Supplementary Concept]
- ETH 157 [MeSH Supplementary Concept]
- ETH 1644 [MeSH Supplementary Concept]
- ETH 1810 [MeSH Supplementary Concept]
- ETH 227 [MeSH Supplementary Concept]
- ETH 5282 [MeSH Supplementary Concept]
- GABA-benzodiazepine receptor-chloride ionophore complex [MeSH Supplementary Concept]
- McN 4308 [MeSH Supplementary Concept]
- N,N',N''-triacetylfusarinine C [MeSH Supplementary Concept]
- N,N,N',N'-tetracyclohexyl-3-oxapentanediamide [MeSH Supplementary Concept]
- N-tert-butyloxycarbonyl-prolyl-alanyl-alanyl-methylamide [MeSH Supplementary Concept]
- N-tert-butyloxycarbonyl-prolyl-glycyl-alanyl-methylamide [MeSH Supplementary Concept]
- O,O'-(2,2'-biphenylene)dithiophosphate pentyl [MeSH Supplementary Concept]
- SF 6847 [MeSH Supplementary Concept]
- T130R2 [MeSH Supplementary Concept]
- X 14547-A [MeSH Supplementary Concept]
- X 14667A [MeSH Supplementary Concept]
- X 14667B [MeSH Supplementary Concept]
- X 14766A [MeSH Supplementary Concept]
- alborixin [MeSH Supplementary Concept]
- antibiotic X 14885A [MeSH Supplementary Concept]
- aplasmomycin [MeSH Supplementary Concept]
- boromycin [MeSH Supplementary Concept]
- bromolasalocid [MeSH Supplementary Concept]
- cationomycin [MeSH Supplementary Concept]
- cephaibol A [MeSH Supplementary Concept]
- cephaibol B [MeSH Supplementary Concept]
- cephaibol C [MeSH Supplementary Concept]
- cezomycin [MeSH Supplementary Concept]
- closantel [MeSH Supplementary Concept]
- cupric schizokinen [MeSH Supplementary Concept]
- cyclo(Glu(O-benzyl)-Sar-Gly-(N-n-decyl)Gly)2 [MeSH Supplementary Concept]
- dianemycin [MeSH Supplementary Concept]
- dihydrogrisorixin [MeSH Supplementary Concept]
- etheromycin [MeSH Supplementary Concept]
- excitability-inducing molecule [MeSH Supplementary Concept]
- ferrimycin [MeSH Supplementary Concept]
- grisorixin [MeSH Supplementary Concept]
- hexadecaisoleucinomycin [MeSH Supplementary Concept]
- humulinic acid [MeSH Supplementary Concept]
- isohumulone [MeSH Supplementary Concept]
- laidlomycin butyrate [MeSH Supplementary Concept]
- leuseramycin [MeSH Supplementary Concept]
- lienomycin [MeSH Supplementary Concept]
- lonomycin [MeSH Supplementary Concept]
- lysocellin [MeSH Supplementary Concept]
- maduramicin [MeSH Supplementary Concept]
- mastoparan, des-Ile(1)-des-Asn(2)- [MeSH Supplementary Concept]
- narasin [MeSH Supplementary Concept]
- omomycin [MeSH Supplementary Concept]
- platelet activating factor phosphatidate [MeSH Supplementary Concept]
- pseudobactin A214 [MeSH Supplementary Concept]
- pyridinophane cryptand [MeSH Supplementary Concept]
- salinomycin [MeSH Supplementary Concept]
- semduramicin [MeSH Supplementary Concept]
- soya-cerebroside I [MeSH Supplementary Concept]
- soya-cerebroside II [MeSH Supplementary Concept]
- t-butyloxycarbonyl-tryptophyl-isoleucyl-alanyl-aminoisobutyryl-isoleucyl-valyl-aminoisobutyryl-leucyl-aminoisobutyryl-proline methyl ester [MeSH Supplementary Concept]
- tetronasin [MeSH Supplementary Concept]
- tetronic 701 [MeSH Supplementary Concept]
- trichogin GA IV [MeSH Supplementary Concept]
- ulapualide A [MeSH Supplementary Concept]
- zincophorin [MeSH Supplementary Concept]
- zincophorin methyl ester [MeSH Supplementary Concept]
Record concept(s)
- ionophores [MeSH concept]
See also
- cell membrane permeability [MeSH Descriptor]
- uncoupling agents [MeSH Descriptor]
See also inter- (CISMeF)
- mobile ion carrier activity [GO term]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- alamethicin [MeSH Descriptor]
- bis-(p-nitrophenyl)ureidodecalin [MeSH Supplementary Concept]
- isopimaric acid [MeSH Supplementary Concept]
- lasalocid [MeSH Descriptor]
- nigericin [MeSH Descriptor]
- nystatin [MeSH Descriptor]
- okadaic acid [MeSH Descriptor]
- valinomycin [MeSH Descriptor]
UMLS correspondences (same concept)
- Ionophore (substance) [SNOMED CT concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients